The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Population Screening Market Compare Between 2026 And 2030?
The population screening market has experienced substantial growth in recent years. This market is projected to expand from $31.39 billion in 2025 to $33.58 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion has been driven by factors such as the broadening of public health screening programs, the presence of suitable laboratory testing infrastructure, a rise in disease awareness initiatives, the development of diagnostic laboratory networks, and the implementation of early detection approaches.
The population screening market size is anticipated to experience substantial expansion over the upcoming years, with projections indicating a rise to $44.61 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period is primarily driven by escalating investments in precision screening technologies, the increasing utilization of population-level health analytics, the expansion of national screening programs, the growing integration of digital diagnostics, and an intensified focus on preventive healthcare models. Significant trends expected during this period include the rising adoption of genomic screening programs, an increase in the use of AI-based risk assessment tools, the growing expansion of preventive health screening, the integration of advanced diagnostic technologies, and enhanced data interpretation capabilities.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp
What Major Factors Are Driving The Population Screening Market Forward?
The escalating incidence of cancer is projected to stimulate the expansion of the population screening market moving ahead. Cancer is characterized as a state where specific cells within the human body multiply uncontrollably and have the potential to spread to other bodily regions, posing considerable health hazards. Population screening aids in the prompt detection of cancer, thereby enhancing therapeutic results and patient outlooks. For example, in February 2024, the World Health Organization, an intergovernmental organization located in Switzerland, indicated that more than 35 million new cancer diagnoses are anticipated by 2050, marking a 77% surge compared to the estimated 20 million cases in 2022. Hence, the increasing prevalence of cancer is propelling the development of the population screening market.
How Is The Population Screening Market Organized By Segment Classification?
The population screening market covered in this report is segmented –
1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation
2) By Gender: Male, Female
3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above
4) By Business: Hospitals, Research Institutes, Diagnostic Labs
Subsegments:
1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment
2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services
3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools
Which Trends Are Impacting The Progress Of The Population Screening Market?
Leading companies within the population screening market are developing advanced services, such as newborn mass screening, to improve early detection and enhance infant health outcomes. Newborn mass screening is a public health initiative where infants are tested shortly after birth for various genetic, metabolic, hormonal, and functional disorders that are not evident at birth but can lead to severe health problems if left untreated. For example, in May 2024, Shimadzu Techno-Research Inc., a contract analysis company and subsidiary of Shimadzu Corporation, a Japan-based manufacturer of precision instruments, introduced a new contract service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will test for combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), conditions that currently affect a small percentage of newborns but demand immediate intervention once diagnosed.
Who Are The Industry Participants Involved In The Population Screening Market?
Major companies operating in the population screening market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., LabPLUS
Get The Full Population Screening Market Report:
https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report
Which Region Is The Top Contributor To The Population Screening Market By Share?
North America was the largest region in the population screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Population Screening Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report
Browse Through More Reports Similar to the Global Population Screening Market 2026, By The Business Research Company
Facility Management Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/facility-management-services-global-market-report
Healthcare Facility Management Market Report
Healthcare Workforce Management System Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model